Advertisement
Overall

Revisits for 8.3 Percent of Patients With Index ER Visit

0
About one-third of revisits occur at different institutions; revisit rates highest for skin infection
The transition to the expanded International Classification of Diseases

ICD-10-CM Challenges ID’d for Emergency Medicine Physicians

0
Twenty-three percent of convoluted codes were found to be clinically incorrect
For premenopausal women and those using hormone replacement therapy

Inverse Link for Coffee Intake, Cholecystectomy Risk

0
Association for premenopausal women, those using HRT but not for other women or for men
Patients aged 55 years and older presenting to an inpatient/emergency department setting with traumatic brain injury have an increased risk of developing Parkinson's disease

TBI Linked to Parkinson’s Risk in Patients Aged ≥55 Years

0
Dose-response associations identified for traumatic brain injury severity and frequency
Women with hypertension and diabetes are less likely to consult with a complementary and alternative medicine (CAM) practitioner and to self-prescribe CAM

Women With HTN, Diabetes Less Likely to Use Alternative Rx

0
Lower odds for consulting complementary and alternative medicine practitioner, taking CAM
Many state policies meant to increase organ donations and transplant rates have had almost no impact

U.S. Organ Donation System Needs ‘Disruptive Innovation’

0
It's time to reward people willing to save a stranger, researchers say
Mortality rates among five-year childhood cancer survivors 15 years after diagnosis have been halved since the 1970s -- falling from 12.4 to 6 percent

ASCO: Longevity Improving for Childhood Cancer Survivors

0
Fewer die of 'late effects' from radiation, chemotherapy

May 2015 Briefing – Internal Medicine

0
Here are what the editors at HealthDay consider to be the most important developments in Internal Medicine for May 2015. This roundup includes the...
For U.S. veterans with posttraumatic stress disorder

Sleep Apnea Risk Found to Rise With PTSD Severity in Veterans

0
Researcher suggests OSA screening for vets presenting for PTSD treatment
The first genetic marker to predict response to pembrolizumab (Keytruda) has been identified by researchers

ASCO: MMR Deficiency Predicts Pembrolizumab Response

0
Findings may help doctors better choose patients to receive pembrolizumab (Keytruda)